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(n¼113 lesions)
Retrograde
(n¼60 lesions) p value
Qualitative Findings:
Subintimal GW tracking, n
(%)*
18 (16) 33 (55) <0.001
Subintimal stenting, n (%) { 11 (9.7) 8 (13) 0.47
Dissection Flap, n (%) 39 (34.5) 42 (70) <0.001
Intramural Hematoma, n (%) 6 (5.3) 17 (28) <0.001
Calciﬁcation (%) 102 (90) 55 (92) 0.76
Calciﬁcation morphology
Superﬁcial (%) 67 (59) 38 (63) 0.6




12 (6 to 18) 17 (13 to 28) 0.01
Subintimal stenting length,
mm
13 (4 to 34) 12.6 (7 to 18) 0.93
Dissection length, mm 5.6 (4 to 9) 5.2 (3 to 9) 0.45
Maximum arc of calcium o 167 (110 to 239) 145 (96 to 194) 0.23
Proximal reference EEM
CSA, mm2
15.5  4.4 15.7  4.2 0.84
Proximal reference lumen
CSA, mm2
9.4  2.8 9.8  3.2 0.38
Distal reference-t EEM CSA,
mm2
8.4  3.4 7.6  2.9 0.15
Distal reference lumen CSA,
mm2
6  2 4.7  1.8 0.01
Post-Stent IVUS
measurements:
Mean stent CSA, mm2 7  1.9 6.7  1.9 0.47
Stent Expansion 0.86  0.33 0.91  0.27 0.34
Stent symmetry index 0.90  0.04 0.90  0.02 0.68
Values are n (%), mean  SD, or median (interquartile range). CSA ¼ cross-sectional area;
EEM ¼ external elastic membrane; GW¼ guidewire; IVUS ¼ intravascular ultrasound.
* immediately after wiring or after pre-dilation with a 1.5 to 2.0-mm balloon.{ ﬁnal guidewire
position in a false lumen with subsequent stent deployment in subintimal spaceConclusions: Intravascular ultrasound effectively differentiates between various GW
induced vessel injuries and depicts subintimal GW tracking. GW crossing with the
retrograde approach was associated with IVUS and angiographic coronary vessel
injuries, which increased the periprocedural complications. The long term clinical and
angiographic outcomes however, were comparable between the antegrade and retro-
grade approaches
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Background: The feasibility of using the BVS in chronic total occlusions (CTO)
lesions is unknown. This study sought to assess the safety, performance and efﬁcacy
of the Absorb everolimus-eluting bioresorbable vascular scaffold (BVS), in percuta-
neous CTO revascularization, under guidance of imaging techniques
Methods: 35 consecutive true CTOs lesions (Euro-CTO club deﬁnition) treated with
BVS were included in this prospective study. Target lesions were scaffold after
mandatory pre-dilatation and IVUS analysis. Optical coherence tomography (OCT)
study was performed after BVS implantation and at 12 months. A multi-slice
computed tomography (MSCT) was performed at baseline and at 6-8 months
Results: The mean age was 60.7  9.7 years old. 80% were male. 20% were diabetic
37% had a previous PCI. The most frequent lesions treated was the RCA (46%).
According to the Japanese-CTO score of complexity most of lesions were classiﬁed as
intermediate (49%) or difﬁcult-very difﬁcult (26%). 34% were moderate-severe
calciﬁed lesions. In most cases (86%) the strategy was antegrade. Pre-dilatation was
100% by cutting balloon in 71%. The total scaffold length implanted per lesion was ofB60 JACC Vol 64/11/Suppl B52.5  22.9mm. All the scaffolds were delivery and deployment successfully. Post-
dilatation was done in 63%. By OCT, ﬁnal minimum scaffold area and lumen stenosis
were of 7.1  1.5mm2 and 11.7  6.6%. There were no signiﬁcant areas of strut
malapposition. At a median of 10.2 (6.2-11.9) months, no MACE was reported and all
the devices were patent by MSCT. At 12-months angiographic follow-up with OCT
was completed in 16 patients, we observed one case of asymptomatic re-occlusion and
2 cases of signiﬁcant scaffold acquired malaposition.
Conclusions: BVS for CTO recanalization demonstrates excellent feasibility, safety
and long-term patency with no MACE at 10 months. At the time of the meeting
completed angiographic follow-up with OCT will be available
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Background: The “hybrid” approach to coronary chronic total occlusion (CTO)
crossing was developed to optimize procedural efﬁcacy, efﬁciency, and safety.
Methods: We examined the procedural techniques and outcomes of 639 consecutive
CTO percutaneous coronary interventions (PCI) performed using the “hybrid”
approach between 2012 and 2014 at 6 US centers.
Results: Mean age was 65  10 years and 86% of the patients were men, with high
prevalence of diabetes mellitus (42%) and prior coronary artery bypass graft surgery
(36%). Most target CTOs were located in the right coronary artery (59%), followed by
the left anterior descending artery (20%) and left circumﬂex (14%). Dual injection was
used in 74%. Overall, antegrade wire escalation was used in 65%, antegrade dissection/
re-entry in 38%, and the retrograde approach in 44%. Among successful cases, the ﬁnal
successful crossing technique was antegrade wire escalation in 42%, antegrade dissection
and re-entry in 27%, and retrograde in 31%. The initial crossing strategy was successful
in 60% of the patients, whereas 40% required an additional 1 to 4 crossing strategies.
Technical success was achieved in 92.6% and a major procedural complication occurred
in 1.7%. Median contrast volume, ﬂuoroscopy time, and air kerma radiation exposure
were 260 (190-360) ml, 42 (26-69) min, and 3.8 (2.2-5.8) Gray, respectively.
Conclusions: Application of the “hybrid” approach to CTO crossing resulted in high
success and low complication rates among a varied operator group and hospital
structure, supporting its expanding use in CTO PCI.
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Background: Although controlled antegrade and retrograde subintimal tracking
(CART) and reverse CART techniques improve the success rate of percutaneous
coronary intervention (PCI) for coronary chronic total occlusions (CTO), the safety
and efﬁcacy of these techniques have not yet been fully evaluated.
Methods: We studied 321 consecutive patients who were performed successful stent
implantation for de novo CTO lesion in our hospital between 2008 and 2013. After
excluding patients who were not performed follow-up coronary angiography after
PCI, ﬁnally 253 patients were examined. Patients were categorized as treated CTO
with CART or reverse CART technique group (CART group: n¼30) versus the
conventional treatment group (control group; n¼223). Angiographic and clinical
outcomes at 8-12 months were compared between the two groups.
Results: At baseline, the occlusion length was signiﬁcantly longer in patients in the
CART group (2117mm vs. 1310mm, p< 0.001) and the mean reference diameter
of the lesion was similar between the two groups (2.700.44mm vs. 2.810.48mm,
p¼0.33). The rate of complication including wire perforation or local dissection of the
coronary artery in the CART group was signiﬁcantly higher than the control group
(17% vs. 4%, p< 0.01). At the 8 to 12 months, there was no signiﬁcant differences in
the restenosis rate (13% vs 13%, p¼0.96). In addition, there was no statistical dif-
ferences between the two groups in angiographic parameters such as minimum lumen
diameter (2.380.86mm vs. 2.340.76mm, p¼0.85), percent diameter stenosis
(1927% vs. 1822%, p¼0.84) and late lumen loss (0.360.70mm vs
0.640.94mm, p¼0.11). During 8-month follow-up after PCI, no difference was
observed between the two groups in terms of major adverse cardiac events (MACEs)j September 13–17, 2014 j TCT Abstracts/Coronary Lesions - CTO
Table. Univariate and multivariate predictors of the primary outcome
Univariate Multivariate





1.8 0.8-4.7 0.18 1.7 0.6-4.9 0.35
Male sex 4.3 0.6-33 0.15 3.3 0.4-25 0.26




1.3 0.9-1.8 0.23 1.1 0.7-1.6 0.80
In-stent occlusion 6.1 2.4-15 0.0001 6.6 2.2-20 0.0008








LM or LAD CTO 0.24 0.03-1.8 0.16 0.4 0.05-3.3 0.41
www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMat 8 months, deﬁned as a composite of death, myocardial infarction and target vessel
revascularization (10% vs 9%, p¼0.91).
Conclusions: Although PCI for CTO with CART or reverse CART technique may be
associated with increased minor complications, it may lead to comparable clinical and
angiographic results at 8 months as compared with conventional treatment.
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Background: The thicker strut of metallic stents potentially contributes to a higher
incidence of side branch occlusion (SBO). This study sought to assess the incidence
and clinical impact of SBO after bioresorbable vascular scaffold (BVS) implantation
in percutaneous CTO revascularization.
Methods: 35 consecutive true CTOs lesions (Euro-CTO club deﬁnition) treated
with BVS were included in this prospective study. Target lesions were scaffold
after mandatory pre-dilatation and IVUS analysis. Side branch occlusion (SBO)
was deﬁned as a reduction in TIMI ﬂow to grade 0 or 1. Accordingly, side
branches (SB) with pre-BVS implantation TIMI ﬂow grade 0 or 1 were excluded.
Visible SB were classiﬁed in two groups: really small (< 0.5mm) or not
( 0.5mm).
Results: The most frequent lesions treated were the RCA (46%) and LAD (40%).
According to the Japanese-CTO score of complexity most of lesions were classiﬁed as
intermediate (49%) or difﬁcult-very difﬁcult (26%). 34% were moderate-severe
calciﬁed lesions. Pre-dilatation was 100% by cutting balloon in 71%. The total
scaffold length implanted per lesion was of 52.5  22.9mm. All the scaffolds were
delivery and deployment successfully. Post-dilatation was done in 63%. The total
number of visible SB covered by BVS was 109 (3.2  1.4 per lesion). SBO after BVS
implantation was described in (7/109) 6.4%. Really small SB (SB< 0.5mm), were
slightly more frequently occluded (4) 3.7% compared to SB 0.5mm (3) 2.8%. In 4 of
7 of cases of SBO, a signiﬁcant dissection after balloon dilatation and before BVS
implantation was observed. However, dissection was reported in 1/4 (25%) of really
small SB and in 3/3 (100%) of bigger SB 0.5mm. Post-procedural SBO was not
related with an increased incidence of in-hospital myocardial infarction. At a median
of 10.2 (6.2-11.9) months, no MACE was reported and all the devices were patent by
MSCT.
Conclusions: In our study with long complex lesions covered by BVS we report a
relatively slow rate of SBO after BVS implantation, including all visible SB.
Moreover it seemed that SBO had not a signiﬁcant impact in in-hospital or mid-
term adverse events. Further investigation is required in a pivotal randomized
trial.
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Background: New techniques involving dissection of the sub-intimal space and re-
entry into the true lumen increase success rates. However, their long-term safety and
efﬁcacy is unknown.
Methods: We assessed the impact of dissection-re-entry techniques and sub-intimal
drug-eluting stent (DES) implantation on longer-term outcomes following successful
chronic total occlusion (CTO) percutaneous coronary intervention (PCI). This study
included a series of consecutive patients who underwent CTO PCI between 01/2010
and 01/2013. Events were collected if patients were re-admitted. If not, they were
contacted 12-18 months after their PCI. The combined incidence of cardiac death,
myocardial infarction, ischemia-driven target vessel revascularisation (TVR) or re-
occlusion was evaluated as our primary outcome.
Results: Out of 212 CTOs treated, 192 (91%) were successfully opened (in 179
patients). Follow-up data was available for 187 CTOs (97.4%), with 82 (44%) that
were opened with dissection-re-entry, and 105 (56%) with wire escalation techniques.
No patient died from cardiac causes. At a median follow-up of 398 days, the primary
outcome occurred in 18/179 CTOs treated (10.7%), driven by TVR. Eleven CTOs
(15.2 %) treated with dissection-re-entry vs. 7 CTOs (7.3%) treated with wire esca-
lation presented with the primary outcome (p¼0.17). With multivariate adjustment,
dissection-re-entry techniques had no signiﬁcant impact on outcomes. However,
treatment of an in-stent occlusion was independently associated with the primary
outcome (HR>6.0; p< 0.001).JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/CoConclusions: Conclusion: Dissection-re-entry techniques have minimal impact on
longer-term outcomes following CTO PCI, which are favorable in the majority of
patients. However, treatment of an in-stent occlusion was a predictor of subsequent
adverse outcomes.
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Background: Bifurcations lesions (BFLs) represent a distinct lesion subset associated
with an increased risk of procedure related complications. Data about incidence,
treatment and clinical outcome of BFLs associated with chronic total occlusions
(CTO) are limited.
Methods: This study is a retrospective analysis of CTO PCI cases performed by a
single CTO experienced operator. Patients with a BFL, within CTO vessel and a side
branch with a reference diameter greater  2 mm were enrolled.
Results: A total of 905 patients (mean age 61.1  9.5 years, males 89.4%) were
treated for 922 CTO lesions. Among them, 244 BFLs within the CTO vessels were
observed (26.5%). Patients with and without BFLs had similar baseline clinical
characteristics except for gender. Furthermore, BFLs were more often observed in left
anterior descending CTO (48.4%) while right coronary artery was the most commonly
involved vessel in non BFLs group (56.6%) (p< 0.001). An angiographic success was
achieved in 91.1% of cases with higher rate in non BFLs (92.5% vs. 87.3%; p¼0.04).
Procedural time was signiﬁcantly longer in BFLs than in non BFLs (139  67 min vs.
124  68 min, respectively; p¼0.003) with a greater use of contrast load (470  193
ml vs.436  227 ml, respectively; p¼0.04) and higher number of stents (3.1  1.5 vs.
2.9  1.4, respectively; p¼0.035). Coronary perforation were more often observed in
BFLs (4.9% vs. 1.7%; p< 0.001) resulting in more tamponades (2.4% vs. 0.2%; p<
0.001). True BFLs were encountered in the majority of cases (86.8%) and required
more 2-stent technique than false BFLs (50% vs. 18.8%; p¼0.001).
Conclusions: The incidence of BFLs in CTO lesions is higher than generally reported
in continuous coronary artery disease patients. The presence of BFLs in a CTO vessel
remains a challenging situation for interventional cardiologists that increases the
complexity of CTO procedure and may lead to less angiographic success and more
peri-procedural complications.
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Background: Laser atherectomy is useful for debulking coronary lesions, but can
cause perforations. While lasers have been used to break down the proximal cap of
chronic total occlusions (CTO) and help create microchannels through non-crossable
lesions, using laser in the extraluminal space has been previously prohibited.
Methods: A retrospective case series was performed of patients who underwent CTO
revascularization using subintimal laser atherectomy with a 0.9 mm laser catheter.
Patients with antegrade subintimal dissection reentry and reverse controlled antegrade-
retrograde dissection (reverse CART) were included. In all cases the laser was
advanced antegrade in the target vessel. Clinical and procedural characteristics, and
outcomes at hospital discharge were collected.
Results: Eleven patients underwent revascularization using laser atherectomy in the
subintimal space. The average J-CTOscorewas 3 0.2 and lesion length 69.5 11.0 cm.ronary Lesions - CTO B61
